Literature DB >> 20494494

[Acute reactive arthritis after intravesical instillation of bacillus Calmette-Guérin. Two case reports and literature review].

S Miranda1, M Verdet, M Vernet, F Héron, O Vittecoq, H Levesque, I Marie.   

Abstract

INTRODUCTION: Intravesical bacillus Calmette-Guérin (BCG) therapy-associated articular complications are uncommon, occurring in only 0.5 to 1% of the patients. OBSERVATIONS: We report two patients who were given intravesical BCG therapy for superficial bladder cancer. Both patients developed polyarthritis and fever related to intravesical BCG instillation. The outcome of articular manifestations was favorable after administration of nonsteroidal anti-inflammatory therapy.
CONCLUSION: Intravesical BCG therapy-associated articular complications should not be overlooked, as they may result in high morbidity. Nevertheless, the diagnosis of intravesical BCG therapy-related reactive arthritis should be discussed after excluding infectious arthritis due to Mycobacterium bovis. Therefore, joint fluid microbiological tests (cultures, PCR) are required in the patients receiving intravesical BCG who develop arthritis. Copyright (c) 2010 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494494     DOI: 10.1016/j.revmed.2010.01.010

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation.

Authors:  Sara Marquez-Batalla; Esther Fraile-Villarejo; Moncef Belhassen-García; Nieves Gutierrez-Zubiaurre; Miguel Cordero-Sánchez
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

2.  Reactive arthritis induced by intravesical BCG therapy for bladder cancer.

Authors:  Kaouther Ben Abdelghani; Alia Fazaa; Leila Souabni; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2014-02-07

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.